Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).
Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT investigators. Lindgren P, et al. Among authors: buxton m. Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):29-36. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 15703503 Clinical Trial.
The effects of cardiac events on quality of life and indirect costs.
Jönsson B, Buxton M, Kahan T, Poulter NR, Svarvar P; Anglo-Scandinavian Cardiac Outcomes Trial, Health Economic Working Group. Jönsson B, et al. Among authors: buxton m. J Hum Hypertens. 2001 Aug;15 Suppl 1:S91-3. doi: 10.1038/sj.jhh.1001214. J Hum Hypertens. 2001. PMID: 11685921 No abstract available.
The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT investigators. Lindgren P, et al. Among authors: buxton m. Pharmacoeconomics. 2009;27(3):221-30. doi: 10.2165/00019053-200927030-00005. Pharmacoeconomics. 2009. PMID: 19354342
Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Jönsson B, Buxton M, Hertzman P, Kahan T, Poulter N; Anglo-Scandinavian Cardiac Outcomes Trial, Health Economics Working Group. Jönsson B, et al. Among authors: buxton m. J Hum Hypertens. 2001 Aug;15 Suppl 1:S53-6. doi: 10.1038/sj.jhh.1001086. J Hum Hypertens. 2001. PMID: 11685911 No abstract available.
319 results